
Roche to Invest $50B for U.S. Expansion, Including New Pharmaceutical Manufacturing Facilities
315INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention to invest $50 billion in the United States over the next five years. The investment will include new and expanded life sciences …